Search research articles
Contact Us
Filters
Showing results (201-210 of 845) with videos related to
Page
of 85
Sort By:
The Journal of Urology
|
July 13, 2012
Re: Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Samir S Taneja
The Journal of Urology
|
July 13, 2012
Re: Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma
Samir S Taneja
The Journal of Urology
|
June 25, 2019
Re: Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends across Risk Groups in the United States, 2010-2015
Samir S Taneja
The Journal of Urology
|
June 25, 2019
Re: Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsies
Samir S Taneja
The Urologic Clinics of North America
|
October 23, 2012
Urologic Clinics of North America. Castrate-resistant prostate cancer. Foreword
Samir S Taneja
The Journal of Urology
|
October 13, 2012
Re: Centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma
Samir S Taneja
The Journal of Urology
|
October 13, 2012
Re: Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma
Samir S Taneja
The Journal of Urology
|
November 16, 2022
Urological Oncology: Prostate Cancer
Samir S Taneja
The Journal of Urology
|
November 8, 2024
Urological Oncology: Prostate Cancer
Samir S Taneja
The Journal of Urology
|
December 20, 2014
Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men
Samir S Taneja
Page
of 85
Search research articles
Search
Showing results (201-210 of 845) with videos related to
Sort By:
Page
of 85
The Journal of Urology
|
July 13, 2012
Re: Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Samir S Taneja
The Journal of Urology
|
July 13, 2012
Re: Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma
Samir S Taneja
The Journal of Urology
|
June 25, 2019
Re: Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends across Risk Groups in the United States, 2010-2015
Samir S Taneja
The Journal of Urology
|
June 25, 2019
Re: Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group than Prostate Imaging Reporting and Data System Score in Multiparametric Prostate Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsies
Samir S Taneja
The Urologic Clinics of North America
|
October 23, 2012
Urologic Clinics of North America. Castrate-resistant prostate cancer. Foreword
Samir S Taneja
The Journal of Urology
|
October 13, 2012
Re: Centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma
Samir S Taneja
The Journal of Urology
|
October 13, 2012
Re: Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma
Samir S Taneja
The Journal of Urology
|
November 16, 2022
Urological Oncology: Prostate Cancer
Samir S Taneja
The Journal of Urology
|
November 8, 2024
Urological Oncology: Prostate Cancer
Samir S Taneja
The Journal of Urology
|
December 20, 2014
Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men
Samir S Taneja
Page
of 85